These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 10683000)
1. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Vermeulen EG; Stehouwer CD; Twisk JW; van den Berg M; de Jong SC; Mackaay AJ; van Campen CM; Visser FC; Jakobs CA; Bulterjis EJ; Rauwerda JA Lancet; 2000 Feb; 355(9203):517-22. PubMed ID: 10683000 [TBL] [Abstract][Full Text] [Related]
2. Effect of homocysteine-lowering treatment with folic acid plus vitamin B on cerebrovascular atherosclerosis and white matter abnormalities as determined by MRA and MRI: a placebo-controlled, randomized trial. Vermeulen EG; Stehouwer CD; Valk J; van der Knaap M; van den Berg M; Twisk JW; Prevoo W; Rauwerda JA Eur J Clin Invest; 2004 Apr; 34(4):256-61. PubMed ID: 15086356 [TBL] [Abstract][Full Text] [Related]
3. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. van Dijk RA; Rauwerda JA; Steyn M; Twisk JW; Stehouwer CD Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2072-9. PubMed ID: 11742887 [TBL] [Abstract][Full Text] [Related]
4. Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial. Vermeulen EG; Rauwerda JA; van den Berg M; de Jong SC; Schalkwijk C; Twisk JW; Stehouwer CD Eur J Clin Invest; 2003 Mar; 33(3):209-15. PubMed ID: 12641538 [TBL] [Abstract][Full Text] [Related]
5. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study. de Jong SC; Stehouwer CD; van den Berg M; Geurts TW; Bouter LM; Rauwerda JA J Intern Med; 1999 Jul; 246(1):87-96. PubMed ID: 10447230 [TBL] [Abstract][Full Text] [Related]
6. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. van den Berg M; Franken DG; Boers GH; Blom HJ; Jakobs C; Stehouwer CD; Rauwerda JA J Vasc Surg; 1994 Dec; 20(6):933-40. PubMed ID: 7990188 [TBL] [Abstract][Full Text] [Related]
7. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520 [TBL] [Abstract][Full Text] [Related]
8. Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. Undas A; Domagala TB; Jankowski M; Szczeklik A Thromb Res; 1999 Sep; 95(6):281-8. PubMed ID: 10527405 [TBL] [Abstract][Full Text] [Related]
9. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM; JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650 [TBL] [Abstract][Full Text] [Related]
10. Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial. Potter K; Lenzo N; Eikelboom JW; Arnolda LF; Beer C; Hankey GJ Cerebrovasc Dis; 2009; 27(3):259-65. PubMed ID: 19202330 [TBL] [Abstract][Full Text] [Related]